mCRC
There a two posters at ESMO. PDAC and mCRC. There are 2 mCRC cohorts.
Cohort 2 - pela plus tecentriq in first-line MSI-high mCRC.
Cohort 3 - pela plus tecentriq plus (TAS-102, Taiho Pharma/China aka Lonsurf/Japan) in third-line mCRC.
The ESMO mCRC is Cohort 3.
I believe the above to be correct. Can anyone enlighten us further?
TIA